Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Cancer Genetics|July 4, 2012
Acute promyelocytic leukemia with a STAT5b-RARα fusion transcript defined by array-CGH, FISH, and RT-PCRHaoyue Chen, Jinlan Pan, Li Yao, et al.
Journal of Leukocyte Biology|October 8, 2021
CTCF: A novel fusion partner of ETO2 in a multiple relapsed acute myeloid leukemia patientJiao Li, Zhen Shen, Zheng Wang, et al.
Leukemia Research|May 5, 2009
The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patientsDandan Liu, Zixing Chen, Yongquan Xue, et al.
Molecular Cancer|April 17, 2015
Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22)Hong Yao, Jinlan Pan, Chunxiao Wu, et al.
British Journal of Haematology|August 18, 2025
Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main cloneHongying You, Weiqin Yao, Lingzhi Yan, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|October 9, 2008
[Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities]Yu Zhu, Wei Xu, Qiong Liu, et al.
Frontiers in Oncology|October 24, 2022
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patientsHongying You, Song Jin, Chunxiao Wu, et al.
Annals of Hematology|June 7, 2024
High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from ChinaZhiyu Zhang, Chunmei Fu, Yingxin Sun, et al.
Experimental Hematology & Oncology|September 29, 2022
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemiaXuanqi Cao, Haiping Dai, Qingya Cui, et al.
Discover Oncology|March 19, 2024
Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myelomaMo Zhou, Yan Chen, Yanlei Gong, et al.
Pageof 9